InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Oki Mark K, Chief Financial Officer. Director active across 1 companies, notably Aytu Biopharma, INC. Aggregated, 2 filings have been published. The latest transaction was filed on 17 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
0100,000 shares0
Common Shares
SEC:0001567619-22-001304·
0100,000 shares0
Common Shares
SEC:0001567619-22-001304:0·
2 of 2 declarations
About Oki Mark K
Oki Mark K is the Chief Financial Officer of AYTU BIOPHARMA, INC. He is responsible for the financial management of the company, including budgeting, financial analysis, and investment management. His expertise is essential in ensuring the financial viability and growth of the company in the biopharmaceutical sector. He plays a key role in financial strategy and decision-making.
